Correlation Between Gossamer Bio and Viridian Therapeutics
Can any of the company-specific risk be diversified away by investing in both Gossamer Bio and Viridian Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gossamer Bio and Viridian Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Gossamer Bio and Viridian Therapeutics, you can compare the effects of market volatilities on Gossamer Bio and Viridian Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gossamer Bio with a short position of Viridian Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gossamer Bio and Viridian Therapeutics.
Diversification Opportunities for Gossamer Bio and Viridian Therapeutics
-0.08 | Correlation Coefficient |
Good diversification
The 3 months correlation between Gossamer and Viridian is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding Gossamer Bio and Viridian Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viridian Therapeutics and Gossamer Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gossamer Bio are associated (or correlated) with Viridian Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viridian Therapeutics has no effect on the direction of Gossamer Bio i.e., Gossamer Bio and Viridian Therapeutics go up and down completely randomly.
Pair Corralation between Gossamer Bio and Viridian Therapeutics
Given the investment horizon of 90 days Gossamer Bio is expected to generate 2.18 times less return on investment than Viridian Therapeutics. But when comparing it to its historical volatility, Gossamer Bio is 1.08 times less risky than Viridian Therapeutics. It trades about 0.04 of its potential returns per unit of risk. Viridian Therapeutics is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 1,447 in Viridian Therapeutics on November 2, 2024 and sell it today you would earn a total of 561.00 from holding Viridian Therapeutics or generate 38.77% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Gossamer Bio vs. Viridian Therapeutics
Performance |
| Timeline |
| Gossamer Bio |
| Viridian Therapeutics |
Gossamer Bio and Viridian Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Gossamer Bio and Viridian Therapeutics
The main advantage of trading using opposite Gossamer Bio and Viridian Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gossamer Bio position performs unexpectedly, Viridian Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viridian Therapeutics will offset losses from the drop in Viridian Therapeutics' long position.| Gossamer Bio vs. Biomea Fusion | Gossamer Bio vs. Stoke Therapeutics | Gossamer Bio vs. Akero Therapeutics | Gossamer Bio vs. Replimune Group |
| Viridian Therapeutics vs. Nuvalent | Viridian Therapeutics vs. Arcellx | Viridian Therapeutics vs. Vaxcyte | Viridian Therapeutics vs. Crinetics Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Complementary Tools
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |